Related Experiment Video
Updated: Aug 8, 2026

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis
Published on: April 17, 2017
Structural determinants that target the hepatitis C virus core protein to lipid droplets
Steeve Boulant1, Roland Montserret2, R Graham Hope3
1Medical Research Council Virology Unit, Institute of Virology, Church St., Glasgow G11 5JR, Scotland, United Kingdom; Institut de Biologie et Chimie des Protéines, CNRS-UMR 5086, IFR128 BioSciences, University of Lyon, 7 Passage du Vercors, Lyon-Gerland, Lyon F-69367, Cedex 07, France.
Abstract:
Hepatitis C virus core protein is targeted to lipid droplets, which serve as intracellular storage organelles, by its C-terminal domain, termed D2. From circular dichroism and nuclear magnetic resonance analyses, we demonstrate that the major structural elements within D2 consist of two amphipathic alpha-helices (Helix I and Helix II) separated by a hydrophobic loop. Both helices require a hydrophobic environment for folding, indicating that lipid interactions contribute to their structural integrity. Mutational studies revealed that a combination of Helix I, the hydrophobic loop, and Helix II is essential for efficient lipid droplet association and pointed to an in-plane membrane interaction of the two helices at the phospholipid layer interface. Aside from lipid droplet association, membrane interaction of D2 is necessary for folding and stability of core following maturation at the endoplasmic reticulum membrane by signal peptide peptidase. These studies identify critical determinants within a targeting domain that enable trafficking and attachment of a viral protein to lipid droplets. They also serve as a unique model for elucidating the specificity of protein-lipid interactions between two membrane-bound organelles.
Related Concept Videos
Hepatitis
Lipids as Anchors
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains the...
Regulation of Nuclear Protein Sorting
Inhibitors of Viral Protein Synthesis
Viral Hepatitis I: Introduction
Inhibitors Of Virion Release

